You need to enable JavaScript to run this app.
Industry groups spar over FDA’s proposed compounding survey
Regulatory News
Joanne S. Eglovitch
Compounding
Pharmaceuticals
Quality Assurance and Control
Regulatory Intelligence/Policy
United States
US Food and Drug Administration (FDA)